RECRUITINGPhase 2INTERVENTIONAL
Examining Mu Opioid Mechanisms of Ketamine's Rapid Effects in OCD (MKET2)
About This Trial
The purpose of this study is to understand how ketamine works in the brain to bring about a reduction in OCD symptoms.
Who May Be Eligible (Plain English)
Eligibility Criteria for Participants with OCD:
Who May Qualify:
- Ages 18-65
- Meet the criteria for OCD diagnosis
- Failed at least 1 prior trial of standard first-line OCD treatment
- Agree to the following lifestyle modifications: comply with requirements for fasting prior to the Experimental Session, not enroll in any other interventional clinical trials during the duration of the study, and commit to medication study procedures.
- Able to provide willing to sign a consent form
Who Should NOT Join This Trial:
- prior naltrexone or ketamine use/exposure
- Any current or past medical/psychiatric condition that makes participation unsafe in the opinion of the investigator or study physician
- Pregnant or nursing, or able to become pregnant and are not practicing an effective means of birth control
- the presence of metal in the body that is contraindicated for MRI scans
Eligibility Criteria for Healthy Volunteers:
Who May Qualify:
- Ages 18-65
- Able to provide willing to sign a consent form
Who Should NOT Join This Trial:
- current or past use of psychotropic medication
- pregnant or nursing females
- the presence of metal in the body that is contraindicated for MRI scans
Always talk to your doctor about whether this trial is right for you.
Original Eligibility Criteria
View original clinical language
Eligibility Criteria for Participants with OCD:
Inclusion Criteria:
* Ages 18-65
* Meet the criteria for OCD diagnosis
* Failed at least 1 prior trial of standard first-line OCD treatment
* Agree to the following lifestyle modifications: comply with requirements for fasting prior to the Experimental Session, not enroll in any other interventional clinical trials during the duration of the study, and commit to medication study procedures.
* Able to provide informed consent
Exclusion Criteria:
* prior naltrexone or ketamine use/exposure
* Any current or past medical/psychiatric condition that makes participation unsafe in the opinion of the investigator or study physician
* Pregnant or nursing, or able to become pregnant and are not practicing an effective means of birth control
* the presence of metal in the body that is contraindicated for MRI scans
Eligibility Criteria for Healthy Volunteers:
Inclusion Criteria:
* Ages 18-65
* Able to provide informed consent
Exclusion Criteria:
* current or past use of psychotropic medication
* pregnant or nursing females
* the presence of metal in the body that is contraindicated for MRI scans
Treatments Being Tested
DRUG
Ketamine
Ketamine is an FDA-approved dissociative anesthetic.
DRUG
Naltrexone Pill
Naltrexone is an oral opioid antagonist approved by the Food and Drug Administration (FDA) to treat both alcohol use disorder (AUD) and opioid use disorder (OUD)
OTHER
Placebo pill
An oral inactive placebo pill will be administered to preserve the blinded nature of the study.
Locations (1)
Department of Psychiatry & Behavioral Sciences
Stanford, California, United States